MedPath

Amobarbital

Generic Name
Amobarbital
Drug Type
Small Molecule
Chemical Formula
C11H18N2O3
CAS Number
57-43-2
Unique Ingredient Identifier
GWH6IJ239E

Overview

A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)

Background

A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)

Indication

中效催眠药,主要用于催眠、镇静、抗惊厥以及麻醉前给药。

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Bausch Health US, LLC
0187-4303
INTRAMUSCULAR, INTRAVENOUS
0.5 g in 5 mL
7/1/2020

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Amobarbital Tablets
国药准字H37020271
化学药品
片剂
2/17/2025
Amobarbital Tablets
国药准字H44020378
化学药品
片剂
1/25/2021
注射用异戊巴比妥钠
国药准字H31021724
化学药品
注射剂
8/13/2020
注射用异戊巴比妥钠
国药准字H31021725
化学药品
注射剂
8/13/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
AMYTAL SODIUM 500mg powder for injection
14617
Medicine
A
9/5/1991
© Copyright 2025. All Rights Reserved by MedPath